Pharmafile Logo
Pharmafocus logo
Advanced Search

‘Open door’ for pharma

December 6, 2012
Sales and Marketing CCGs, NHS, NICE, Pharmafocus, Prescriber, UK

The NHS’s new clinical commissioning groups (CCGs) will be more welcoming to approaches from pharma than the old PCTs were, …

News
nhs_trees

‘Risk share’ with us, say CCGs

December 6, 2012
Sales and Marketing CCGs, NHS, Pharmafocus, Prescriber, pharma

Pharma companies have been urged to “put your head on the block” by coming up with risk-sharing funding plans for …

News
hans_008_4189455_rohde_hans

uniQure appoints Basilea’s chief commercial officer

December 6, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Basilea, uniQure

Dutch human gene therapy firm uniQure has appointed Hans Christian Rohde as chief commercial officer. Rohde joins uniQure from Basilea …

Appointment
screen_shot_2012-12-05_at_10

ImmunoCellular appoints Andrew Gengos as chief executive

December 5, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Gengos, ImmunoCellular

Clinical stage firm ImmunoCellular Therapeutics has announced the appointment of Andrew Gengos as president and chief executive and member of …

Appointment
Bayer image

New boost for drug candidates

December 5, 2012
Research and Development, Sales and Marketing Bayer, EFPIA, K4DD, Leiden

A new project is trying to increase the hit rates of successful drug candidates by improving the way they are …

News

Trajenta may reduce stroke damage

December 4, 2012
Research and Development, Sales and Marketing Boehringer, EMA, Trajenta, diabetes, linagliptin

Boehringer Ingelheim’s  diabetes drug Trajenta could one day be used to minimise the effects of brain damage following stroke. Scientists …

News

Excipient certification project moves forward

December 4, 2012
Manufacturing and Production DEG, EXCiPACT, GDP, GMP

The EXCiPACT certification scheme for pharmaceutical excipients has taken a step closer to fruition with agreements now in place with …

News

R&D costs rise ten-fold

December 4, 2012
Research and Development, Sales and Marketing OHE, R&D, research and development

Research by the Office of Health Economics (OHE) think tank shows that the cost of pharma R&D has risen ten-fold …

News
Chris Ham image

NHS ‘entering treacherous waters’

December 3, 2012
Sales and Marketing Ham, NHS, coalition, king's fund, reforms

A leading think tank has marked the coalition government’s health policy with what amounts to a C+ in its mid-term …

News

J&J’s Alex Gorsky to be chairman and chief executive

December 3, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Johnson & Johnson has has elected its chief executive Alex Gorsky to be its chairman of the Board of directors.  …

Appointment

Pharmacos ink green manufacturing pact with EU academics

December 3, 2012
Manufacturing and Production Bayer, EU, Pharmacos, Sanofi

A group of top pharma multinationals have set up a public-private partnership dedicated to the development of manufacturing sustainable pharmaceuticals …

News
janssen image

Janssen eases HIV patent burden

December 3, 2012
Sales and Marketing AIDS, Janssen, Prezista, darunavir

In a move which should appeal to public health campaigners, Janssen has declared that it will not enforce patents for …

News
NHS image

Help CCGs help you, pharma told

November 30, 2012
Medical Communications, Sales and Marketing CCGs, JSNA, NHS, pharma

Pharma companies have a big opportunity to take advantage of the changes in the structure of the NHS, according to …

News
Ranbaxy image

Ranbaxy suspends atorvastatin manufacturing after recall

November 30, 2012
Manufacturing and Production FDA, Ranbaxy, atorvastatin, recall

Ranbaxy Laboratories has called a halt to manufacturing its generic atorvastatin product until it can get to the bottom of …

News
mr_subhanu_saxena__1276617e

New chief executive for Cipla

November 30, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Cipla, Subhanu Saxena

Indian pharma firm Cipla has announced the appointment of Novartis’ Subhanu Saxena as its chief executive. Saxena joins Cipla in …

Appointment
NICE image

NICE: ‘lot of work’ to do on VBP

November 30, 2012
Medical Communications, Sales and Marketing Boysen, NHS, NICE, QALY, VBP

NICE is still working out what its role with the new NHS Commissioning Board will be, with other key issues …

News
Novartis image

Novartis R&D warning

November 29, 2012
Research and Development, Sales and Marketing NHS, Novartis. R&D, trials

Novartis has hit out at what it sees as the high cost of UK clinical trials, warning that business will …

News
Eylea image

Eylea approval for wet AMD

November 29, 2012
Sales and Marketing Bayer, Eylea, Lucentis, Novartis, avastin, wet AMD

Bayer HealthCare’s Eylea has been appoved in Europe for the treatment of neovascular age-related macular degeneration (wet AMD). The eye …

News
screen_shot_2012-11-28_at_15

Genzyme appoints new GM for UK and Ireland

November 29, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brendan Martin, Genzyme

Genzyme has announced the appointment of Brendan Martin as general manager for UK and Ireland. Martin will be responsible for …

Appointment

Survey: pharma losing $564 billion each year

November 28, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cap Gemini, Health Prize, pharma

Pharma companies are losing $564 billion each year – more than half the industry’s $956 billion revenue worldwide last year …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026